Looks like Dr. Moro has decided not to respond to our recent request for an update. I suspect he won't respond until he finally has a steady revenue stream or something substantial to report ie., another license agreement or FDA submission by Inverness . Silence might be the best approach at this time although frustrating for shareholders. I'm not aware of any other publically traded company that keeps shareholders abreast of all the minute details required to get a product to market, so why should we expect that kind of information from Dr. Moro.

I don't think Dr. Moro released the press release about dog RECAF simply to pump the stock as some would have us believe. I'm sure he has a handle on the market potential for such a product. He told us he would be able to give more details about this project in a couple of months, one month ago. Hang tight, there's a lot going on behind the scenes.

I suspect Dr. Moro must have gotten the necessary financing he was pursuing, otherwise he would have to disclose a default on the Smithline loan to shareholders. Don't forget he was talking to 20 different groups that were interested in providing some type of financing. Some how he manages to keep this company/technology moving forward. I look forward to the day he's able to silence all the naysayers.

Happy investing to all Biocurex shareholders!

JHMO